Polycystic ovary syndrome
- PMID: 17720020
- DOI: 10.1016/S0140-6736(07)61345-2
Polycystic ovary syndrome
Abstract
Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.
Similar articles
-
Polycystic Ovary Syndrome.Obstet Gynecol. 2018 Aug;132(2):321-336. doi: 10.1097/AOG.0000000000002698. Obstet Gynecol. 2018. PMID: 29995717 Review.
-
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.Arch Gynecol Obstet. 2006 Jul;274(4):227-32. doi: 10.1007/s00404-006-0173-8. Epub 2006 May 12. Arch Gynecol Obstet. 2006. PMID: 16691383
-
Polycystic ovarian syndrome.Med Clin North Am. 2015 Jan;99(1):221-35. doi: 10.1016/j.mcna.2014.09.003. Epub 2014 Nov 22. Med Clin North Am. 2015. PMID: 25456652 Review.
-
Metabolic Syndrome: Polycystic Ovary Syndrome.FP Essent. 2015 Aug;435:30-42. FP Essent. 2015. PMID: 26280343 Review.
-
Polycystic ovary syndrome and female reproduction.Br J Nurs. 2007 Oct 11-24;16(18):1118-21. doi: 10.12968/bjon.2007.16.18.27504. Br J Nurs. 2007. PMID: 18073681 Review.
Cited by
-
Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.Endocrine. 2013 Dec;44(3):583-90. doi: 10.1007/s12020-013-9971-5. Epub 2013 Apr 27. Endocrine. 2013. PMID: 23625194 Review.
-
Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis.Iran J Reprod Med. 2015 Apr;13(4):227-30. Iran J Reprod Med. 2015. PMID: 26131012 Free PMC article.
-
Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.Sci Rep. 2016 Jul 27;6:30679. doi: 10.1038/srep30679. Sci Rep. 2016. PMID: 27461373 Free PMC article.
-
The Beneficial Effects of Lacticaseibacillus paracasei subsp. paracasei DSM 27449 in a Letrozole-Induced Polycystic Ovary Syndrome Rat Model.Int J Mol Sci. 2024 Aug 9;25(16):8706. doi: 10.3390/ijms25168706. Int J Mol Sci. 2024. PMID: 39201391 Free PMC article.
-
The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Int J Endocrinol. 2020 Sep 16;2020:5150684. doi: 10.1155/2020/5150684. eCollection 2020. Int J Endocrinol. 2020. PMID: 33014044 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical